INTERVISION GUIDELINES INTERVISION GUIDELINES Table of contents Acknowledgements ....................................................................................................…

1. Hépatite B La vaccination Françoise DEGOS Hôpital Beaujon, Clichy 2.   3. Estimated Incidence of Acute Hepatitis B United States, 1978-1995 Vaccine licensed HBsAg…

Slide 1MAP Network State of the Art The Status and Trends of HIV/AIDS Epidemics Karen Stanecki, US Census Bureau and Chair of Monitoring the AIDS Pandemic Network Slide 2…

Slide 1The need to challenge unhealthy drug policies to improve drug treatment Dr Chris Ford, Holly Catania and Rebecca Murchie IDHDP Slide 2 IDHDP Purpose To increase the…

Slide 1NICE Guidance on Needle and Syringe Programmes: Providing Injecting Equipment to People who Inject Drugs. Professor Mike Kelly, PhD, FFPH. Director, The Centre for…

Slide 1Peer naloxone – present or future? Issues for service delivery Nigel Modern Slide 2 Current status of Take Home Naloxone We have good evidence of effectiveness in…

Slide 1Needle and syringe programmes Implementing NICE guidance 2009 NICE public health guidance 18 Slide 2 What this presentation covers Background Scope Recommendations…

Slide 1HIV/AIDS: Insight Into Its Impact Part-I Prasanta K. Saha, M.Sc., CSTAT (UK), FRSS (UK). Chartered Statistician [RSS-UK], Visiting Fellow: University of Hawaii [EWC],…

Slide 1The Connecticut AIDS Residence Coalition, Inc. If only 100 people in CT had HIV/AIDS… Slide 2 The Connecticut AIDS Residence Coalition, Inc. If only 100 people in…

Slide 1HIV/AIDS Presentation for WELL Seminar 2012 Slide 2 Fact or Myth? Africa has been more affected by AIDS than any other part of the world, but HIV infection rates are…